Press releaseGlobe Newswire
Alimera Sciences
ALIM · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- Press releaseBusiness Wire
ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger
- NewsAvi Kapoor
Crude Oil Dips Over 4%; OPEC Cuts Global Oil Demand Outlook
- NewsAvi Kapoor
Dow Dips Around 1%; US Small Business Optimism Falls In August
- Press releaseBusiness Wire
Alimera Sciences Takes Legal Action Against ANI Pharmaceuticals to Enforce Merger Agreement
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALIM, INFN on Behalf of Shareholders
- Press releaseBusiness Wire
ALIMERA SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alimera Sciences, Inc. - ALIM
- Press releaseGlobe Newswire
Alimera Sciences Reports Second Quarter 2024 Results
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, DOMA, CALT on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALIM, DOMA, CALT on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIM
- Press releasePRNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. - ALIM
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.